Review article · 2026 · Open access
AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases
Drug Discovery Today, 31(6), 104836 · Published 16 October 2026 · DOI 10.1016/j.drudis.2026.104836
In brief
“AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases” is a 2026 review article by Soukaina Amniouel and 3 co-authors, published in Drug Discovery Today. OpenAlex counts 0 citations as of 17 November 2026. It is open access under a CC BY licence: the full text is free to read at Drug Discovery Today.
- Citations
- 0
- References
- 83
- Authors
- 4
Abstract
Rare diseases represent a major unmet medical need, yet the development of therapeutics for these diseases is limited by small patient cohorts, fragmented data, and uncertain disease mechanisms. Recent advances that combine patient-derived induced pluripotent stem cell (iPSC) models with multi-omics profiling and artificial intelligence offer a robust approach for phenotype definition and drug target identification that requires only minimal patient material. By integrating transcriptomic, proteomic, and metabolomic data, machine learning can produce disease-relevant molecular signatures, identify convergent pathway drivers, and prioritize druggable targets despite limited sample sizes. This short review highlights emerging in vitro models and AI-enabled workflows, discusses their strengths and limitations, and outlines practical strategies to accelerate drug discovery for rare diseases.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Amniouel, S., Shyr, Z. A., Mathé, E. A., & Zheng, W. (2026). AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases. Drug Discovery Today, 31(6), 104836. https://doi.org/10.1016/j.drudis.2026.104836
MLA 9
Amniouel, Soukaina, et al. “AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases.” Drug Discovery Today, vol. 31, no. 6, 2026, p. 104836. https://doi.org/10.1016/j.drudis.2026.104836.
Chicago
Amniouel, Soukaina, Zeenat A. Shyr, Ewy A. Mathé, and Wei Zheng. 2026. “AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases.” Drug Discovery Today 31 (6): 104836. https://doi.org/10.1016/j.drudis.2026.104836.
Harvard
Amniouel, S. et al. (2026) ‘AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases’, Drug Discovery Today, 31(6), p. 104836. doi:10.1016/j.drudis.2026.104836.
IEEE
S. Amniouel, Z. A. Shyr, E. A. Mathé, and W. Zheng, “AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases,” Drug Discovery Today, vol. 31, no. 6, p. 104836, 2026, doi: 10.1016/j.drudis.2026.104836.
BibTeX
@article{amniouel2026integrated,
title = {{AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases}},
author = {Amniouel, Soukaina and Shyr, Zeenat A. and Mathé, Ewy A. and Zheng, Wei},
journal = {Drug Discovery Today},
year = {2026},
volume = {31},
number = {6},
pages = {104836},
doi = {10.1016/j.drudis.2026.104836},
url = {https://doi.org/10.1016/j.drudis.2026.104836}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- rare diseases
- induced pluripotent stem cells
- iPSC-derived disease models
- multi-omics integration
- artificial intelligence
- drug target identification
- transcriptomics
- proteomics
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Amniouel, S., Shyr, Z. A., Mathé, E. A., & Zheng, W. (2026). AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases. Drug Discovery Today, 31(6), 104836. https://doi.org/10.1016/j.drudis.2026.104836
How many times has this paper been cited?
0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Drug Discovery Today: sign in and open the PDF from this page.
Who wrote this paper?
Soukaina Amniouel, Zeenat A. Shyr, Ewy A. Mathé, Wei Zheng.
What is the DOI of this paper?
10.1016/j.drudis.2026.104836, permanently at https://doi.org/10.1016/j.drudis.2026.104836. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.